IART Q3 2019 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$379M+3.6% YoY

Gross Profit

$236M62.4% margin

Operating Income

-$21M-5.4% margin

Net Income

-$28M-7.3% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-1.2%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

-$44M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$2.0B

Stockholders' Equity

$1.4B

Cash & Equivalents

$208M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$379M	$366M	+3.6%
Gross Profit	$236M	$223M	+6.2%
Operating Income	-$21M	$24M	-186.9%
Net Income	-$28M	$13M	-307.7%

Revenue Segments

Codman Specialty Surgical

$253M67%

Orthopedics and Tissue Technologies

$126M33%

Geographic Segments

UNITED STATES

$266M70%

Europe

$49M13%

Asia Pacific

$42M11%

Rest Of World

$21M6%